Regeneron Pharmaceutical Stock Sees Composite Rating Move Up To 96

Regeneron Pharmaceutical (REGN) saw an improvement in its IBD SmartSelect Composite Rating Monday, from 94 to 96.

The upgrade means the stock is now outperforming 96% of all other stocks in terms of key performance metrics and technical strength. The top-performing stocks tend to have a 95 or better grade as they begin to launch a significant move.  Be sure to keep that in mind when looking for the best stocks to buy and watch.

Regeneron Pharmaceutical stock broke out earlier, but has fallen back below the prior 659.89 entry from a cup with handle. If a stock you’re tracking clears a buy point then declines 7% or more below the original entry price, it’s considered a failed base. You can wait for the stock to set up and breakout from a new chart pattern and buy point, although this one seems to have rebounded today.

Looking For Winning Stocks? Try This Simple Routine


The stock sports a 99 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth tops 99% of all stocks.

Its Accumulation/Distribution Rating of C shows a roughly equal amount of buying and selling by institutional investors over the last 13 weeks.

In Q3, the company posted 84% EPS growth. Revenue growth fell to 51%, down from 163% in the previous quarter.

Regeneron Pharmaceutical stock earns the No. 2 rank among its peers in the Medical-Biomed/Biotech industry group. Evotec (EVO) is the top-ranked stock within the group.


Join IBD Live And Learn Top Chart-Reading And Trading Techniques From The Pros
MarketSmith’s Tools Can Help The Individual Investor
Profit From Short-Term Trends With SwingTrader
Get Timely Buy & Sell Alerts With IBD Leaderboard
Find The Best Long-Term Investments With IBD Long-Term Leaders

IBD Digital: Get access to subscriber-only stock lists and market analysis. Plus, add the weekly print edition for your weekend prep.

Most Related Links :
Business News Governmental News Finance News

Need Your Help Today. Your $1 can change life.

[charitable_donation_form campaign_id=57167]

Source link

Back to top button